OPKO Health, Inc. Senior Notes, Current
OPKO Health, Inc. (OPK) had Senior Notes, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:SeniorNotesCurrent · last filed 2020-03-02
- 2019-12-31: Senior Notes, Current $0.00.
- 2018-12-31: Senior Notes, Current $31.56M.
- 2018-09-30: Senior Notes, Current $30.96M.
- 2018-06-30: Senior Notes, Current $30.34M.
| Period end | Senior Notes, Current |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2018-12-31 | $31.56M 10-K · filed 2020-03-02 |
| 2018-09-30 | $30.96M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $30.34M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $29.74M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |